ENCell Co., Ltd. (KOSDAQ:456070)
16,280
-180 (-1.09%)
Apr 29, 2026, 3:30 PM KST
ENCell Revenue
In the year 2025, ENCell had annual revenue of 5.26B KRW, down -27.06%. ENCell had revenue of 1.44B in the quarter ending December 31, 2025, a decrease of -31.07%.
Revenue
5.26B
Revenue Growth
-27.06%
P/S Ratio
34.44
Revenue / Employee
n/a
Employees
n/a
Market Cap
181.08B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Macrogen | 195.27B |
| Vaxcell-Bio Therapeutics | 1.90B |
| MedPacto | 3.90B |
| Amicogen | 41.98B |
| Genexine | 5.81B |
| JETEMA, | 76.90B |
| EASY BIO,Inc. | 476.94B |
| iNtRON Biotechnology | 5.74B |